https://www.marketscreener.com/quote/stock/IMMUNIC-INC-57237730/news/Immunic-Inc-Announces-FDA-Clearance-to-Begin-IMU-838-Phase-3-ENSURE-Studies-in-Relapsing-Remitti-35764629/?utm_source=telegram&utm_medium=social&utm_campaign=share